|
KMID : 0380020100250060507
|
|
Korean Journal of Biotechnology and Bioengineering
2010 Volume.25 No. 6 p.507 ~ p.512
|
|
|
Anti-cancer Effects of Luteolin and Its Novel Mechanism in HepG2 Hepatocarcinoma Cell
|
|
Hwang Jin-Taek
Yang Hye-Jung
|
|
|
Abstract
|
|
|
|
In this study, we investigated the ability of luteolin, a plant derived flavonoid on hepatocarcinoma cell growth using HepG2 cell culture system. We found that luteolin increased the Smac/DIABLO releases, a mitochondrial protein that potentiates apoptosis. Luteolin also induced either transcriptional activity or expression of PPAR-gamma, a target of cancer growth that PPAR-gamma agonist sensitizes to apoptosis in certain cancer types. To find the possible upstream target molecules of PPAR-gamma activated by luteolin treatment, we used compound C, a specific inhibitor of AMP-activated protein kinase. Pre-treatment of Compound C significantly restored the activation or expression of PPAR-gamma stimulated by luteolin. This result indicated that AMPK signaling might be involved in the activation or expression of PPAR-gamma signaling pathway stimulated by luteolin. Moreover, we also found that luteolin inhibited the insulin-stimulated Akt phosphorylation as well as AICAR, a specific AMPK activator. These results propose that luteolin significantly induces cancer cell death through modulating survival signal pathways such as PPAR-gamma and Akt. AMPK signaling pathway may be an upstream regulator for survival signal pathways such as PPAR-gamma and Akt stimulated by luteolin.
|
|
|
KEYWORD
|
|
|
Luteolin, Anti-cancer, PPAR-gamma, AMP-activated protein kinase, Akt
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|